𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B

✍ Scribed by Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim; Sunyong Kim

Book ID
113064268
Publisher
Springer US
Year
2011
Tongue
English
Weight
199 KB
Volume
57
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiviral efficacy of combination therap
Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H

Adefovir-based combination therapy with
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B
✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV ΓΎ LAM therapy